Metrics as of 10/16/2026, 05:54 PM (Berlin time), refresh in progress.
ResMed Stock
ResMed Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Michael J. Farrell
- Employees
- 11,370
- Market cap
- $33.6 B
- IPO
- 02/06/1995
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. Headquartered in San Diego, USA, the company was founded in 1989. ResMed operates through two primary segments: Sleep and Respiratory…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
ResMed stock: price history
1D
-1.3%
1W
+3.9%
1M
+4.7%
6M
+4.8%
YTD
-0.8%
1Y
-11.5%
2Y
+0.3%
5Y
-6.5%
10Y
+269.6%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~80% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 12/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about ResMed
Analyst assessment of ResMed
PRICE TARGET LOW
US$213.00
CONSENSUS
US$243.56
MEDIAN
US$230.00
PRICE TARGET HIGH
US$300.00
0
STRONG BUY
14
BUY
16
HOLD
5
SELL
0
STRONG SELL
35
TOTAL · Hold
As of: 15/09/2026
ResMed stock metrics
P/E
22.89
P/B
5.25
EV/EBITDA
15.21
RETURN ON EQUITY
5.8%
NET MARGIN
26.2%
DEBT/EQUITY
0.13
DIVIDEND YIELD
1.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.1%
FLOAT SHARES
139,315,728
AVG. DAILY VOLUME (30D)
1,195,375
Insider transactions (SEC)
Farrell Michael J.
Farrell Michael J.
Rider Michael J
Leong Justin
Farrell Michael J.
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.3%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about ResMed stock
What does ResMed do?
ResMed Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Michael J. Farrell, the company employs around 11,370 people.
The IPO was on 02/06/1995; the stock trades on NYSE under the ticker RMD.
What do analysts say about ResMed stock?
35 analysts rate the stock, the consensus is Hold (as of 15/09/2026).
The average price target is US$243.56, ranging from US$213.00 to US$300.00, with a median of US$230.00.
This is an external assessment, not a statement by Market Jury.
When does ResMed report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 80% stronger than usual.
Does ResMed pay a dividend?
Yes. The last dividend was US$0.66 per share, ex-date 20/08/2026, paid on 24/09/2026.
The dividend yield is 1.0% (as of 30/06/2026).
Which stocks are comparable to ResMed?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies, Avantor and Repligen.
How can I get ResMed stock analyzed?
Clicking "Analyze stock" lets five strategies assess ResMed against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.